Press Release: CytoDyn Appoints Richard Pestell, M.D., Ph.D. as Lead Consultant in Oncology

Dow JonesNov 25, 2024 08:31 ET

CytoDyn Announces FDA Clearance of Its Phase II Oncology Trial

GlobeNewswireNov 4, 2024 08:30 ET

Express News | Cytodyn Announces FDA Clearance of Its Phase II Oncology Trial

ReutersNov 4, 2024 08:30 ET

CytoDyn Appoints Dr. Melissa Palmer, M.D., as Lead Consultant in Hepatology; Announces Follow-Up Inflammation Studies With SMC Laboratories

GlobeNewswireOct 30, 2024 08:30 ET

CYTODYN INC | 10-Q: Q1 2025 Earnings Report

SECOct 15, 2024 17:20 ET · Announcements

Press Release: CytoDyn Appoints Dr. Max Lataillade as Senior Vice President and Head of Clinical Development

Dow JonesOct 8, 2024 08:32 ET